The Valley Desk

ArticleACS medicinal chemistry lettersPublished

Discovery of 5‑Azaindole Inhibitors of O‑GlcNAcase for the Treatment of Alzheimer's Disease and Related Tauopathies

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

Publication record

Type
Article
Venue
ACS medicinal chemistry letters
Published
Subject terms
Alzheimer’s disease; Tau Pathology; Structure-based Design; 5-Azaindole; O-glcnacase Inhibitors
PubMed ID
42157845
PubMed Central ID
PMC13181490
Added to directory
Source checked

Report a correction or request removal